Tag: alexion pharmaceuticals

May 28, 2019

8 Small Biotech ETFs

Want to invest in small biotech ETFs? Here we profile eight that life science investors may want to look into.
March 26, 2019

7 Potential Blockbuster Drugs Investors Should Watch for in 2019

A report by Cortellis says that seven drugs entering the market in 2019 are projected to reach blockbuster status by...
September 24, 2018

Alexion Announces Successful Phase 3 PREVENT Study of Soliris (Eculizumab) in Patients with Neuromyelitis Optica Spectrum Disorder

Alexion Pharmaceuticals (NASDAQ:ALXN) today announced positive topline results from the Phase 3 PREVENT study of Soliris (eculizumab) in patients with anti-aquaporin-4 (AQP4)...
June 28, 2018

Alexion Submits Application for Approval of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria in the EU

Alexion Pharmaceuticals (NASDAQ:ALXN) announced the submission of a Marketing Authorization Application to the European Medicines Agency (EMA) for ALXN1210, the...
February 26, 2018

Positive Regulatory News from Two Pharmaceutical Companies Triggers Share Price Increases

Investors and analysts are focusing on KemPharm and Achillion after both companies received recent positive regulatory news.
April 25, 2017

biOasis Technologies Appoints New CEO

biOasis Technologies announced the appointment of Dr. Mark Day as president and CEO of the company.
March 19, 2017

5 Top NASDAQ Biotech Stocks: Cerulean Pharma gained 118.42 percent

Cerulean Pharma leads the list of last week's life science gainers on the NASDAQ, followed by Catalyst Pharmaceutical, Neovasc, Arbutus...